Sommer R, Bullinger M, Chaplin J, Do JY, Power M, Pleil A, Quitmann J. Experiencing health-related quality of life in paediatric short stature - a cross-cultural analysis of statements from patients and parents. Clin Psychol Psychother, 2017,24(6):1370-1376.
 Aguirre GA, De Ita JR, de la Garza RG and Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med, 2016,14:3.
 Wormser D, Angelantonio ED, Kaptoge S, Wood AM, Gao P, Sun Q, Walldius G, Selmer R, Verschuren WM, Bueno-de-Mesquita HB, et al. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol, 2012,41(5):1419-1433.
 Song Y M. Adult Height and Cause-specific Mortality: A Large Prospective Study of South Korean Men. Am J Epidemiol, 2003,158(5):479-485.
 Song Y M, Sung J. Adult Height and the Risk of Mortality in South Korean Women. Am J Epidemiol, 2008,168(5):497-505.
 Paajanen TA, Oksala NKJ, Kuukasjärvi P and Karhunen PJ. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J, 2010,31(14):1802-1809.
 Ferrie JE, Langenberg C, Shipley MJ and Marmot MG. Birth weight, components of height and coronary heart disease: evidence from the Whitehall II study. Int J Epidemiol, 2006,35(6):1532-1542.
 Jolliffe C J, Janssen I. Distribution of Lipoproteins by Age and Gender in Adolescents. Circulation, 2006,114(10):1056-1062.
 Pyles LA, Lilly C, Mullett C, Polak E, Elliott E, Neal WA. LDL Cholesterol Level in Fifth Grade School Children Associates with Stature. J Lipid Res, 2017, 58: 2197-2201.
 Koskinen J, Juonala M, Dwyer T, et al. Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: International Childhood Cardiovascular Cohort Consortium. Circulation, 2018,137(12): 1246-125 5.
 Raitakari O T, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA, 2003,290(17):2277-2283.
 Juonala M, Magnussen C G, Venn A, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation, 2010,122(24):2514-2520.
 Tada H, Nohara A, Kawashiri M. Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies. Nutrients, 2018,10(11):1789.
 Boullart A C I, de Graaf J, Stalenhoef A F. Serum triglycerides and risk of cardiovascular disease. Biochim Biophys Acta, 2012,1821(5):867-875.
 Ye X, Kong W, Zafar MI, Chen L. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovascular Diabetology, 2019,18(1).
 Nordestgaard B G, Varbo A. Triglycerides and cardiovascular disease. Lancet, 2014, 384(9943): 626-635.
 Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation, 2007,115(4):450-458.
 Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Heart Study. Am J Epidemiol, 2007,166(5):527-533.
 Ma W, Cui C, Feng S, Li G, Han G, Hu Y, Li X, Lv J, Liu C, Jin F. Serum Uric Acid and Triglycerides in Chinese Patients with Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study. BioMed Res Int, 2019,2019:1-7.
 Cibičková Ľ, Langová K, Vaverková H, Kubíčková V, Karásek D. Correlation of uric acid levels and parameters of metabolic syndrome. Physiol Res, 2017,66(3):481-487.
 Mukhopadhyay P, Ghosh S, Pandit K, Chatterjee P, Majhi B, Chowdhury S. Uric acid and its correlation with various metabolic parameters: A population-based study. Indian J Endocrinol Metab, 2019;23(1):134-139.
 Lurbe E, Torro MI, Alvarez-Pitti J, Redon J, Borghi C, Redon P. Uric acid is linked to cardiometabolic risk factors in overweight and obese youths. J Hypertens, 2018,36(9):1840-1846.
 Zhao Q, Jiang Y, Zhang M, Chu Y, Ji B, Pan H, Ban B. Low-density lipoprotein cholesterol levels are associated with insulin-like growth factor-1 in short-stature children and adolescents: a cross-sectional study. Lipids Health Dis, 2019,18(1):120.
 Wang P, Ji B, Shao Q, Zhang M, Ban B. Association between Insulin-Like Growth Factor-1 and Uric Acid in Chinese Children and Adolescents with Idiopathic Short Stature: A Cross-Sectional Study. BioMed Res Int, 2018,2018:1-6.
 Rogol A D, Hayden G F. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr, 2014,164(5 Suppl):S1-S14.
 Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Chinese J Pediatr, 2009,47(7):487-492.
 Wright CM, Ahmed L, Dunger DB, Preece MA, Cole TJ, Butler G. Can we characterise growth in puberty more accurately? Validation of a new Puberty Phase Specific (PPS) growth chart. Arch Dis Child, 2012,97(Suppl 1):A100.
 Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, Teramoto A, Tatsumi KI, Tachibana K, Katsumata N. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J, 2012,59(9):771-780.
 Feig D I, Johnson R J. Hyperuricemia in Childhood Primary Hypertension. Hypertension, 2003,42(3):247-252.
 Li L, Song Q, Yang X. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults. J Diabetes Res, 2019, 2019:1-8.
 Xu L, Li T, Yin J, Lin G, Xu Y, Ren Y, Wang Y, Yang J, Chen L. Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. PeerJ, 2019,7:e7563.
 Russo E, Leoncini G, Esposito P, Garibotto G, Pontremoli R and Viazzi F. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. Int J Mol Sci, 2020,21(12):4479.
 Borghi C. The role of uric acid in the development of cardiovascular disease. Curr Med Res Opin, 2015,31 Suppl 2:1-2.
 Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes, 2011,60(4):1258-1269.
 Parvez A, Ihsanullah, Rafiq A, Ahmad N and Khan EH. Relationship of glycaemia and triglycerides with BMI in diabetic patients. J Ayub Med Coll Abbottabad, 2010,22(2):164-166.
 McAdams M A, Van Dam R M, Hu F B. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity, 2007,15(1):188-196.
 Dai S, Eissa MA, Steffen LM, Fulton JE, Harrist RB and Labarthe DR. Associations of BMI and its fat-free and fat components with blood lipids in children: Project HeartBeat!. Clin Lipidol, 2011,6(2):235-244.
 La Batide-Alanore A, Trégouët DA, Sass C, Siest G, Visvikis S and Tiret L. Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort. Int J Epidemiol, 2003,32(4):607-614.